Non-Invasive Embryo Testing
Our Team
8/20/2026
Embryo testing has long been one of the most debated topics in reproductive medicine. For many years, preimplantation genetic testing (PGT) has been used to identify embryos with chromosomal abnormalities or genetic differences before embryo transfer, helping physicians gather additional information during the IVF process. As technology continues to evolve, researchers have been exploring new ways to improve embryo assessment, including the development of non-invasive embryo testing.
Traditional PGT requires embryologists to remove a small number of cells from the embryo's outer layer for genetic analysis. While this procedure is widely used and generally considered safe, it is still classified as invasive because it involves directly manipulating the embryo. This has led scientists to investigate methods that may provide similar genetic information without the need for a biopsy.
Non-invasive embryo testing takes a different approach by analyzing DNA that is naturally released by the embryo into the surrounding culture medium as it develops in the laboratory. Because the embryo is not directly biopsied, this technique has generated considerable interest within the fertility field. If future research demonstrates that the method is accurate and reliable, it could reduce laboratory manipulation of embryos, simplify genetic testing procedures, and potentially expand access to embryo testing.
Despite its promise, non-invasive embryo testing is still an emerging technology. Current scientific literature has not yet shown that DNA collected from spent culture media performs as consistently or as reliably as established embryo biopsy techniques. Researchers continue to study how best to collect, analyze, and interpret this DNA, as well as the factors that may influence test accuracy.
As with many advances in reproductive medicine, continued research will determine the future role of non-invasive embryo testing in IVF. While the technology remains an exciting area of investigation, ongoing studies will be essential to understanding its potential benefits, limitations, and place alongside existing embryo testing methods.
To learn more about non-invasive embryo testing, listen to Dr. Norbert Gleicher discuss the topic in the latest episode of The Egg Factor. Access the episode using the link below.
https://www.buzzsprout.com/2187935/episodes/19591881
Recent Posts
Stem Cells and Future Fertility Treatments
Stem cells and their potential role in fertility treatment are one of the most exciting areas of reproductive science research today.
AI in Embryo Selection
Artificial intelligence (AI) is quickly becoming part of modern medicine, including reproductive medicine.
Press Release: The CHR Announces a Clinical Trial
The CHR announces a clinical trial of the drug Finerenone in infertile women with POA and POI.